Blaine Davis

Companies

• Selecta Biosciences (United States)Chief financial officer Nov 30, 2022 to now¹
• Proteon TherapeuticsChief financial officer Feb 11, 2020 to Jul 19, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SBSelecta Biosciences (United States) RNAC121,220 shares³$794.7K at $6.56Jan 6, 2026
• Proteon Therapeutics TARA20,662 shares⁴$49.2K at $2.38Jul 15, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 6, 2026Sold 10,591 shares at $6.82 of Selecta Biosciences (United States)³
• Jan 2, 2026Granted 37,000 shares of Selecta Biosciences (United States)⁵
• Jan 6, 2025Sold 4,028 shares at $16.83 of Selecta Biosciences (United States)⁶
• Jan 3, 2025Sold 3,961 shares at $16.72 of Selecta Biosciences (United States)⁶
• Jan 2, 2025Granted 22,000 shares of Selecta Biosciences (United States)⁷
• Jan 2, 2024Granted 2,424,000 shares of Selecta Biosciences (United States)⁸
• Jul 15, 2022Shares withheld for tax 5,081 shares at $3.13 of Proteon Therapeutics⁴
• Jan 3, 2022Granted 14,100 shares of Proteon Therapeutics⁹